惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Microsoft Azure Blog
Microsoft Azure Blog
The Register - Security
The Register - Security
S
Securelist
Simon Willison's Weblog
Simon Willison's Weblog
T
The Exploit Database - CXSecurity.com
V
Vulnerabilities – Threatpost
NISL@THU
NISL@THU
P
Privacy & Cybersecurity Law Blog
V2EX - 技术
V2EX - 技术
O
OpenAI News
N
News and Events Feed by Topic
AI
AI
P
Proofpoint News Feed
Schneier on Security
Schneier on Security
Exploit-DB.com RSS Feed
Exploit-DB.com RSS Feed
Cloudbric
Cloudbric
Help Net Security
Help Net Security
C
Cyber Attacks, Cyber Crime and Cyber Security
Threat Intelligence Blog | Flashpoint
Threat Intelligence Blog | Flashpoint
Security Latest
Security Latest
Application and Cybersecurity Blog
Application and Cybersecurity Blog
L
LINUX DO - 热门话题
Cyberwarzone
Cyberwarzone
Scott Helme
Scott Helme
The Hacker News
The Hacker News
Hacker News - Newest:
Hacker News - Newest: "LLM"
www.infosecurity-magazine.com
www.infosecurity-magazine.com
Google DeepMind News
Google DeepMind News
H
Hacker News: Front Page
C
Cisco Blogs
Webroot Blog
Webroot Blog
K
KPMG report finds enterprise disconnect between AI and its ROI | CIO
Hacker News: Ask HN
Hacker News: Ask HN
cs.CL updates on arXiv.org
cs.CL updates on arXiv.org
The Last Watchdog
The Last Watchdog
PCI Perspectives
PCI Perspectives
AWS News Blog
AWS News Blog
Recent Commits to openclaw:main
Recent Commits to openclaw:main
Know Your Adversary
Know Your Adversary
Latest news
Latest news
Forbes - Security
Forbes - Security
I
Intezer
Project Zero
Project Zero
C
CERT Recently Published Vulnerability Notes
T
Tenable Blog
TaoSecurity Blog
TaoSecurity Blog
S
Security @ Cisco Blogs
N
News | PayPal Newsroom
H
Heimdal Security Blog
W
WeLiveSecurity

Forbes - Healthcare

The Trump Administration Is Shifting Federal Policy On Cannabis And Psychedelics How to Prevent Domestic Violence Deaths UK Smoking Ban Highlights Debate Over The Proper Function Of Government What To Do When Someone You Love Has Cancer Psychedelic Medicine Goes Mainstream: Breakthrough or Bubble? Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly What Are Peptides And Why Is Everyone Talking About Them? Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might Does Retail Pharmacy Have A Tower Records Problem? Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices Over A Million Road Crash Deaths Annually Prompt $350 Million Investment Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast Large Study Finds Benefits Of Doula Care On Postpartum Outcomes TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? America Can’t Lower Healthcare Costs Without A Moonshot Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis Mark Cuban’s Cost Plus Drugs, Humana Partner To Take On Employer Drug Costs Cell, Gene And Specialty Drug Costs Intensify For Health Plans New AMA Study Finds Burnout Is Decreasing Among Medical Residents And Fellows Daytime Naps May Be A Sign Of Serious Health Problems, Study Reveals New Antibody Drugs Target Disease From Within Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading Who Is Actually Qualified To Give Advice On Peptides And Who Isn’t What the 49ers Can Teach Leaders About Handling False And Misleading Narratives Do Older Adults Need Routine Colonoscopies Or Low Thyroid Drugs? Your Period, Your Proteins, Your Health Doctors Say Hegseth’s Flu Vaccine Decision Will Weaken Military Readiness Where Bullets Fly, Malaria Kills Using AI To Personalize Healthcare–Without Losing Patient Trust Progress For Preeclampsia Allowing Our Military To Refuse Flu Vaccination Is A Bad Idea. Here’s Why Can Vaccine Development Weather Political Storms? A Virus From Farmed Seafood Is Causing A New Eye Disease In People Elevance Health Profits Eclipse $1.7 Billion Despite Elevated Costs The UK Passes A Lifetime Smoking Ban. Could America Be Next? There's No Such Thing As Brain Honey UnitedHealth Group Profits Eclipse $6 Billion As Medical Costs Ease AI Is Already Here. The Real Risk In Public Health Is Sitting It Out UnitedHealthcare Reduces Need For Prior Approvals For Patients In Rural America Why No Child Should Have To Sacrifice School To Care For Their Family Oscar Health Launches Consumer Marketplace For Insurance Beyond Its Own Calling The Iconic 867-5309 Now Goes To A Cancer Helpline FDA Lists Xanax Recall. Here’s What You Need To Know What Trump’s Ibogaine Executive Order Means For Veterans With PTSD 20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs Rotavirus Is Surging Across The US — Here’s What Parents Need To Know Leadership Dysfunctional In Healthcare: “Split The Baby” Thinking ‘Bedtime Stacking’ Trends On TikTok. Here Are The Risks Why Do Weight Loss Drugs Work For Some And Not Others? It’s In The Genes Hospital Safety: How to Avoid Medical Errors and Protect Yourself Medicare Can Save $4 Billion On Four Cancer Drugs — Can You Guess Which Ones? After 25 Years Of Consumer-Directed Healthcare, What’s Missing? This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster RFK Jr. Pushes To Expand Access To Peptides. A Doctor Explains The Risks How The Trump Administration Is Blocking Access To Home Care Genome Sequencing Solves Rare Disease Mysteries Breakthrough HIV Drug Is Out Of Reach For Many Who Need It Most New Drug Protects Against Life-Threatening Pancreatitis This Pill May Help Pancreatic Cancer Patients Live Longer What Should We Do When The Patient Is Racist? Attention Turns To UnitedHealth Earnings For Signs Of Insurer Rebound New Pancreatic Cancer Drug Nearly Doubles Survival. Here’s What Patients Should Know Why Sex Exists A Novel Approach To The Treatment Of Antibiotic Resistant Infections Democrat-Leaning Plan Takes Aim At Health Plans With New Regulations Trump Administration Weighs Default Medicare Advantage Plans For Seniors An AI System Passed Peer Review. The Scientific Community Isn’t Ready Prior Authorization Reform Is Here — And It Could Change How Millions Get Care The More We Add To U.S. Healthcare, The Worse It Gets How Two Sisters Built A $1 Billion HealthTech Unicorn CDC Delays Reporting Of COVID-19 Vaccine Benefits—Here’s What To Know This Startup Wants To Use AI To Help Digitize History Are Nicotine Pouches Like Zyn And VELO Safe To Use? A Doctor Answers America’s Healthcare Innovation Problem GLP-1 Weight Loss Drugs Are Easy To Get—But Are They Safe? Why Cleveland Clinic Chose This AI Startup To Rewire Key Healthcare Operations Upset About The High Price Of Your Hospital Stay? Medicaid Cuts Might Be To Blame Trump’s New Pharmaceutical Tariffs Will Hit Small Drugmakers Hardest A New Way To Target Metastatic Cancer What A Florida Birth Case Reveals About Post-Dobbs Maternal Healthcare 5 Reasons Why the Medicare Program Can’t Go Broke Lowering Healthcare Costs Without A Disastrous Government-Run Model Promising Study Links Coffee Consumption To Reduced Dementia Risk Gene Regulation May Control How Long We Live Health Insurers Get 2.5% Medicare Rate Hike They Feared Would Be Flat Engineered Antibodies Pry Apart The Most Difficult Viruses Centene Latest Health Insurer To Shakeup Management Ranks 1.6 Million Teens Are Vaping. Health Risks Are Worse Than You Think Increasing Burdens Medical Debt And Bankruptcy Are Uniquely American Medicaid Work Requirements Go Live Soon. Here’s How Many Could Lose Coverage What SpaceX’s IPO Means For The Space Economy Thus Far, Most Favored Nation Drug Prices Have Had Little Impact FDA Approves New Oral Weight Loss Pill Foundayo — Here’s What To Know ‘Medicare By Choice’ Plans Could Work, But More Details Needed Criticism of NFL's Rooney Rule Misses How Hiring Actually Works Navigating Health In The Age Of Misinformation NASA Artemis II astronaut health risks explained
U.S. Tennis Participation Continues Growth. Up 54 Percent Since 2019
Bruce Y. Lee · 2026-04-27 · via Forbes - Healthcare
Patrick McEnroe

Patrick McEnroe (R), seen here commenting for the TV broadcast of the 2025 US Open Tennis Championships with brother John McEnroe, recently spoke to me about the continuing increase in tennis participation in the U.S. (Photo by Jean Catuffe/GC Images)

GC Images

What goes up, like a tennis ball, must come down, right? Well, that hasn’t really applied to tennis participation, though. At least, not yet since the start of the COVID-19 pandemic.

For the sixth consecutive year, the number of tennis player in the U.S. has grown, according to the recently-released 2026 U.S. Tennis Participation Report. Last year, 2025, U.S. tennis participation bounced up further by 1.6 million players to 27.3 million Americans. That’s around a six percent increase if you don’t have an abacus or enough fingers handy to count and calculate.

Patrick McEnroe, a former professional tennis player and captain of the U.S. Davis Cup team and a current tennis broadcaster and co-director of the John McEnroe Tennis Academy, called this “a boom for tennis the last five years.” He told me about how the JMTA courts on Randall’s Island in New York City “went from 20 to 29 courts and from four to eight every day, every court is packed with four to five kids per courts. So, not only are adults playing, but we’ve been able to attract a lot more kids and keep them in it.”

Since 2019 U.S. Tennis Participation Has Grown By 54 Percent

Yeah, tennis has been making quite a racket throughout the 2020s. It began with nature sort of dropping a deuce on everyone and the U.S. being ill-prepared to handle it. In March 2020 when the severe acute respiratory syndrome coronavirus 2 was spreading in an uncontrolled fashion, the U.S. had to scramble to flatten the curve—remember that?—and buy time to figure out what to do. With no clear overarching pandemic response strategy, the default was to have lots of things just shut down kind of indefinitely at the time.

I wrote about all that in Forbes in 2020 and how with no real guidance on how Americans could stay physical active and socializing, tennis served up an opportunity to do both while maintaining enough distance from each other to prevent virus transmission. “I think we all know why in the pandemic [tennis participation grew], because there wasn’t a lot that people could do sporting-wise and activity wise,” McEnroe recalled. “Tennis was one of the sports that people could play.” That year saw a 22 percent increase in tennis participation as I covered in Forbes.

But even as society bounced back from 2020, tennis participation did not. No, instead it kept bouncing forward. And I kept writing about this remarkable spin on things, in 2022, 2023, 2024 and 2025. That’s because this has been one of the continuing feel-good stories from the COVID-19 pandemic. The result has been tennis participation growing by a whopping 54 percent since 2019. Those six consecutive years of growth have added nearly 10 million players top the courts in this country.

4.9 Million Picked Up Tennis Racquets For The First Time In 2025

The report was based on responses to the Physical Activity Council Study on Sports and Physical Activity and the PLAY Study, formerly known as the Participation and Engagement Study. These two studies consist of surveying each year a total of around 36,000 people in the U.S. Survey responses also showed that 4.9 million picked up tennis racquets for the first time in 2025. This was nine percent more racquet newbies than there were in 2024.

Oh, and the surveys showed that what happened on the court tended to stay on the court as well. Most tennis players have kept on dropshotting rather than dropping out of the sport with sround 20.7 million players sticking with the sport in 2025. That’s a 10 percent increase from 2024. There also seemed to be many happy returns with 1.7 million players coming back to tennis after having been away for more than a year.

Then there are the tennis curious. Based on survey results, an estimated 25 million Americans who currently don’t play tennis do have a lot of interest in playing. They may not have the balls or the racquets or whatever to do so right now. But they could someday add to the total.

More Tennis Participation Could Mean More Health Benefits For More People

Patrick McEnroe, Vice-Captain of Team World speaks with Frances Tiafoe of Team World (Left wearing a Chelsea FC shirt) during a Team World Practice Session at Uber Arena on September 19, 2024 in Berlin, Germany. (Photo by Maja Hitij/Getty Images for Laver Cup)

Getty Images for Laver Cup

What happened in 2025 means that the U.S. Tennis Association is in a good position to reach its goal of 35 million players by 2035. Brian Vahaly, Chairman of the Board and Interim Co-CEO, USTA, had talked to me previously about this goal. He had also used the moniker "world’s healthiest sport” when describing tennis.

Now whenever you use the descriptor world’s top anything—with the possible exception of world’s best food, which is sushi— you may get a debate. Nevertheless, there’s no denying that tennis can bring a variety of health benefits and can be played by people of nearly all ages.

“I can’t tell you how many people I see that come out, you know, in their 70s, 80s, and 90s, and they’re still playing tennis,” McEnroe related. “I’m playing actually with a woman next Monday whom I know from the theater, and she’s been playing and she’s going to turn 97. Every year the past five years on her birthday, I go into the city and I play with her and her coach and her friend at her club.”

The body and mind benefits of tennis make the tennis boom truly a feel-good story, no strings attached. McEnroe emphasized, “You have to pretty much use every part of your body and your brain because of all those factors, tracking the ball, seeing the ball, connecting with the ball, timing, awareness and obviously, movement."

Tennis Participation Continues To Grow More And More Diverse

Now, one historical image of tennis in this country that the USTA has been trying to dispel is that tennis is somehow a sport for “the elite.” I’ve already written about some of the USTA’s programs to bring greater diversity into the sport. But there have been other efforts beyond the USTA, too, such as what the JMTA has been doing. “Our charitable wing that’s part of the Academy has basically raised money for scholarships to take tennis into the local schools in the South Bronx and in Harlem that are close to Randalls Island,” McEnroe explained. “Some of those kids end up in our regular Johnny Mac Tennis Academy.” He added, “When I look at the background of the kids in our program, I would say it’s a pretty wide range of kids now. There are African-American kids, Asian kids and Eastern European kids that get into tennis. We’re in New York City, so we’re trying to bring in as diverse a background of kids as we can. But you can always do more."

The survey results suggest that programs around the country are indeed working to increase diversity in participation. Last year saw increases in the number of Black/African Americans playing tennis by over 450,000 (14 percent), Hispanic/Latino players by over 550,000 (12 percent) and Asian/Pacific Islander players by over 260,000 (10 percent). As you may have noticed, these numbers are greater percentage increases than the overall player increase. And the sport courted 1.1 million more women in 2025 than in 2024. That’s a 10 percent increase from 2024.

It’s now clear that tennis participation has continued to be on the up and up, well past the pandemic. And more people from a greater range of backgrounds are indeed having a ball, which serve the USTA well in trying to reach the 35 million goal by 2035.